Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HZ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HZ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HZ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HZ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-14857.5South Korea
FU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FU.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FU.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FU.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FU.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.3.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.3.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.43ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.43ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used